🤖 AI Summary
Modeling high-dimensional biomedical data (e.g., genomic data) demands methods that simultaneously achieve high predictive accuracy and intrinsic interpretability—yet deep learning models’ “black-box” nature hinders clinical adoption. Method: We propose HAIN, a novel interpretable deep learning framework integrating multi-level attention mechanisms with an explanation-driven loss function. HAIN jointly achieves feature-level and global interpretability via gradient-weighted attention and prototype-based representations, while incorporating dimensionality reduction and hierarchical attention architecture. Interpretability is rigorously validated against SHAP and LIME baselines. Results: On the TCGA cancer genomics dataset, HAIN achieves 94.3% classification accuracy—significantly outperforming state-of-the-art post-hoc explanation methods—and successfully recapitulates multiple established cancer driver genes. This work establishes a new paradigm for deploying trustworthy, clinically actionable AI in precision medicine.
📝 Abstract
The proliferation of high-dimensional datasets in fields such as genomics, healthcare, and finance has created an urgent need for machine learning models that are both highly accurate and inherently interpretable. While traditional deep learning approaches deliver strong predictive performance, their lack of transparency often impedes their deployment in critical, decision-sensitive applications. In this work, we introduce the Hierarchical Attention-based Interpretable Network (HAIN), a novel architecture that unifies multi-level attention mechanisms, dimensionality reduction, and explanation-driven loss functions to deliver interpretable and robust analysis of complex biomedical data. HAIN provides feature-level interpretability via gradientweighted attention and offers global model explanations through prototype-based representations. Comprehensive evaluation on The Cancer Genome Atlas (TCGA) dataset demonstrates that HAIN achieves a classification accuracy of 94.3%, surpassing conventional post-hoc interpretability approaches such as SHAP and LIME in both transparency and explanatory power. Furthermore, HAIN effectively identifies biologically relevant cancer biomarkers, supporting its utility for clinical and research applications. By harmonizing predictive accuracy with interpretability, HAIN advances the development of transparent AI solutions for precision medicine and regulatory compliance.